Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii

Journal of Bacteriology

Volumn 194, Issue 15, 2012, Pages 3950-3960

  Bentancor, Leticia V ^a   Camacho Peiro, Ana ^a   Bozkurt Guzel, Cagla ^a   Pier, Gerald B ^a   Maira Litrán, Tomás ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER TRIMERIC AUTOTRANSPORTER; ADHESIN; AMINO ACID; COLLAGEN TYPE 4; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOFILM; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; BIOFILMS; COLLAGEN; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS;

ACINETOBACTER; ACINETOBACTER BAUMANNII; MUS;

EID: 84866329652     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.06769-11     Document Type: Article

References (80)

1. American Association for Pediatrics. 2006. Pertussis (whooping cough). Red Book Online 2006:498-520.
2. Beavers SF, et al. 2009. Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006. Public Health Rep. 124:868-874.
3. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Breslow JM, et al. 2011. Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect. Immun. 79:3317-3327.
6. Brooks MJ, et al. 2008. Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function. Infect. Immun. 76:5330-5340.
7. Caricato A, et al. 2009. Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Med. 35:1964-1969.
8. Chiang D-H, et al. 2008. Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification. J. Microbiol. Immunol. Infect. 41:397-402.
9. Choi AHK, Slamti L, Avci FY, Pier GB, Maira-Litran T. 2009. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N-acetylglucosamine, which is critical for biofilm formation. J. Bacteriol. 191:5953-5963.
10. Choi CH, et al. 2008. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell Microbiol. 10:309-319.
11. Choi CH, et al. 2005. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol. 7:1127-1138.
12. Choi CH, Lee JS, Lee YC, Park TI, Lee JC. 2008. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol. 8:216. doi:10.1186/1471-2180-8-216.
13. Cisneros JM, et al. 1996. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin. Infect. Dis. 22:1026-1032.
14. Clark JG, Kuhn C, McDonald JA, Mecham RP. 1983. Lung connective tissue. Int. Rev. Connect. Tissue Res. 10:249-331.
15. Comanducci M, et al. 2002. NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195:1445-1454.
16. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
17. Cotter SE, Surana NK, St Geme JW. 2005. Trimeric autotransporters: a distinct subfamily of autotransporter proteins. Trends Microbiol. 13:199-205.
18. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269:10566-10573.
19. Davis KA, Moran KA, McAllister CK, Gray PJ. 2005. Multidrugresistant Acinetobacter extremity infections in soldiers. Emerg. Infect. Dis. 11:1218-1224.
20. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951.
21. Dizbay M, Tunçcan OG, Sezer BE, Hizel K. 2010. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scand. J. Infect. Dis. 42:741-746.
22. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
23. D'Souza SE, Ginsberg MH, Burke TA, Lam SC, Plow EF. 1988. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 242:91-93.
24. Finn TM, Stevens LA. 1995. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol. Microbiol. 16:625-634.
25. Gaddy JA, Tomaras AP, Actis LA. 2009. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 77:3150-3160.
26. Garcia-Garmendia J, et al. 2001. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin. Infect. Dis. 33:939-946.
27. Gómez J, et al. 1999. Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 18:358-361.
28. Guex N, Peitsch MC. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
29. Hauck CR, Agerer F, Muenzner P, Schmitter T. 2006. Cellular adhesion molecules as targets for bacterial infection. Eur. J. Cell Biol. 85:235-242.
30. Hawley JS, et al. 2007. Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob. Agents Chemother. 51: 376-378.
31. Hellwig SMM, Rodriguez ME, Berbers GAM, van de Winkel JGJ, Mooi FR. 2003. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J. Infect. Dis. 188:738-742.
32. Henderson IR, Owen P. 1999. The major phase-variable outer membrane protein of Escherichia coli structurally resembles the immunoglobulin A1 protease class of exported protein and is regulated by a novel mechanism involving Dam and oxyR. J. Bacteriol. 181:2132-2141.
33. Humphries J, Byron A. 2006. Integrin ligands at a glance. J. Cell Sci. 119:3901-3903.
34. Jacobs AC, et al. 2010. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect. Immun. 78:1952-1962.
35. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. 2009. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J. Hosp. Infect. 73:143-150.
36. Jin JS, et al. 2011. Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS One 6:e17027. doi: 10.1371/journal.pone.0017027.
37. Joly-Guillou ML, Wolff M, Pocidalo JJ, Walker F, Carbon C. 1997. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob. Agents Chemother. 41:345-351.
38. Reference deleted.
39. Jones DT. 2007. Improving the accuracy of transmembrane protein topology prediction using evolutionary information. Bioinformatics 23: 538-544.
40. Kapoor R. 2008. Acinetobacter infection. N. Engl. J. Med. 358:2845-2847.
41. Lautenbach E, et al. 2009. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect. Control Hosp. Epidemiol. 30: 1186-1192.
42. Lee H-W, et al. 2008. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 14:49-54.
43. Lee JC, et al. 2006. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res. Microbiol. 157:360-366.
44. Linke D, Riess T, Autenrieth IB, Lupas A, Kempf VAJ. 2006. Trimeric autotransporter adhesins: variable structure, common function. Trends Microbiol. 14:264-270.
45. Livak K. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔ CT method. Methods 25:402-408.
46. Loehfelm TW, Luke NR, Campagnari AA. 2008. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J. Bacteriol. 190:1036-1044.
47. Reference deleted.
48. Maira-Litran T, Kropec A, Goldmann DA, Pier GB. 2005. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetylbeta-(1-6)-glucosamine. Infect. Immun. 73:6752-6762.
49. Maragakis LL, Perl TM. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46: 1254-1263.
50. McConnell MJ, et al. 2011. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect. Immun. 79:518-526.
51. Metan G, Sariguzel F, Sumerkan B. 2009. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur. J. Intern. Med. 20:540-544.
52. Nielsen M, Lundegaard C, Lund O, Petersen TN. 2010. CPHmodels-3.0-remote homology modeling using structure-guided sequence profiles. Nucleic Acids Res. 38:W576-W581.
53. Nishimura K, Tajima N, Yoon Y-H, Park S-Y, Tame JRH. 2010. Autotransporter passenger proteins: virulence factors with common structural themes. J. Mol. Med. 88:451-458.
54. Oncül O, et al. 2002. Hospital-acquired infections following the 1999 Marmara earthquake. J. Hosp. Infect. 51:47-51.
55. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microb. Rev. 21:538-582.
56. Perez F, et al. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484.
57. Pettersen EF, et al. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
58. Pride DT, Meinersmann RJ, Blaser MJ. 2001. Allelic variation within Helicobacter pylori babA and babB. Infect. Immun. 69:1160-1171.
59. Richet H, Fournier PE. 2006. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect. Control Hosp. Epidemiol. 27:645-646.
60. Rodríguez-Baño J, et al. 2004. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect. Control Hosp. Epidemiol. 25:819-824.
61. Rodríguez-Hernández MJ, et al. 2000. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J. Antimicrob. Chemother. 45:493-501.
62. Roggenkamp A, et al. 2003. Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhesin YadA. J. Bacteriol. 185: 3735-3744.
63. Russo TA, et al. 2010. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 78:3993-4000.
64. Scarselli M, et al. 2006. Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesin. Mol. Microbiol. 61:631-644.
65. Seifert H, Strate A, Pulverer G. 1995. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine 74:340-349.
66. Serruto D, et al. 2010. Neisseria meningitidis GNA2132, a heparinbinding protein that induces protective immunity in humans. Proc. Natl. Acad. Sci. U. S. A. 107:3770-3775.
67. Smith MG, et al. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21:601-614.
68. Song JY, Cheong HJ, Lee J, Sung AK, Kim WJ. 2009. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Int. J. Antimicrob. Agents 33:33-39.
69. Steyert SR, Pineiro SA. 2007. Development of a novel genetic system to create markerless deletion mutants of Bdellovibrio bacteriovorus. Appl. Environ. Microbiol. 73:4717-4724.
70. St Geme JW, Kumar VV, Cutter D, Barenkamp SJ. 1998. Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae. Infect. Immun. 66:364-368.
71. Surana NK, Cutter D, Barenkamp SJ, St Geme JW. 2004. The Haemophilus influenzae Hia autotransporter contains an unusually short trimeric translocator domain. J. Biol. Chem. 279:14679-14685.
72. Tahir YE, Kuusela P, Skurnik M. 2000. Functional mapping of the Yersinia enterocolitica adhesin YadA. Identification of eight NSVAIG-S motifs in the amino-terminal half of the protein involved in collagen binding. Mol. Microbiol. 37:192-206.
73. Tien HC, et al. 2007. Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect. Dis. 7:95. doi: 10.1186/1471-2334-7-95.
74. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. 2003. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149:3473-3484.
75. van der Woude MW, Henderson IR. 2008. Regulation and function of Ag43 (Flu). Annu. Rev. Microbiol. 62:153-169.
76. van Faassen H, et al. 2007. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun. 75:5597-5608.
77. Wang Y, et al. 2010. Causes of Infection after earthquake, China, 2008. Emerging Infect. Dis. 16:974-975.
78. Wollmann P, Zeth K, Lupas AN, Linke D. 2006. Purification of the YadA membrane anchor for secondary structure analysis and crystallization. Int. J. Biol. Macromol. 39:3-9.
79. Zhang P, et al. 2004. A family of variably expressed outer-membrane proteins (Vomp) mediates adhesion and autoaggregation in Bartonella quintana. Proc. Natl. Acad. Sci. U. S. A. 101:13630-13635.
80. Zimbler DL, et al. 2009. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals 22:23-32.